Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Rexahn Pharmaceuticals (REXN)

Rexahn Pharmaceuticals (REXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Rexahn Pharmaceuticals 15245 SHADY GROVE ROAD SUITE 455 ROCKVILLE MD 20850 USA

www.rexahn.com P: 240-268-5300

Description:

REXAHN PHARMACTICALS is a biopharmaceutical company leveraging its proprietary technology platform to discover, develop and commercialize innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs. Rexahn's compounds are designed to uniquely treat various disease states while significantly minimizing side effects in order to allow patients to regain quality of life through therapy.

Key Statistics

Overview:

Market Capitalization, $K 8,115
Shares Outstanding, K 4,483
Annual Sales, $ 0 K
Annual Net Income, $ -8,640 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,510 K
60-Month Beta 1.08
% of Insider Shareholders 1.10%
% of Institutional Shareholders 7.49%
Float, K 4,434
% Float 98.90%

Growth:

1-Year Return -11.71%
3-Year Return -92.75%
5-Year Return -96.57%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/04/20
Earnings Per Share ttm -1.26
EPS Growth vs. Prev Qtr -313.33%
EPS Growth vs. Prev Year -1.64%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 11/06/20

REXN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -79.33%
Return-on-Assets % -58.43%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales 7.06
Price/Cash Flow N/A
Price/Book 1.42
Book Value/Share 1.74
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar